These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37289152)

  • 1. [Treatment of giant cell arteritis].
    Samson M; Greigert H; Bonnotte B
    Rev Prat; 2023 Apr; 73(4):395-399. PubMed ID: 37289152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of giant cell arteritis.
    González-Gay MÁ; Pina T; Prieto-Peña D; Calderon-Goercke M; Gualillo O; Castañeda S
    Biochem Pharmacol; 2019 Jul; 165():230-239. PubMed ID: 31034796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and emerging diagnosis tools and therapeutics for giant cell arteritis.
    González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
    Expert Rev Clin Immunol; 2018 Jul; 14(7):593-605. PubMed ID: 29877748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
    JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostics and treatment of giant cell arteritis].
    Kraemer M; Becker J; Bley TA; Steinbrecher A; Minnerup J; Hellmich B
    Nervenarzt; 2022 Aug; 93(8):819-827. PubMed ID: 34734295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing treatment options for large vessel vasculitis.
    Macaluso F; Marvisi C; Castrignanò P; Pipitone N; Salvarani C
    Expert Rev Clin Immunol; 2022 Aug; 18(8):793-805. PubMed ID: 35714219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerance of methotrexate in a real-life monocentric cohort of patients with giant cell arteritis.
    Lavergne A; Dumont A; Deshayes S; Boutemy J; Maigné G; Silva NM; Nguyen A; Gallou S; Philip R; Aouba A; de Boysson H
    Semin Arthritis Rheum; 2023 Jun; 60():152192. PubMed ID: 36963127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).
    Spiera RF; Mitnick HJ; Kupersmith M; Richmond M; Spiera H; Peterson MG; Paget SA
    Clin Exp Rheumatol; 2001; 19(5):495-501. PubMed ID: 11579707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glucocorticoids in the treatment of giant cell arteritis : How much, how long and how to spare?].
    Hellmich B
    Z Rheumatol; 2021 May; 80(4):322-331. PubMed ID: 33710440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymyalgia Rheumatica and Giant Cell Arteritis: Rapid Evidence Review.
    Raleigh MF; Stoddard J; Darrow HJ
    Am Fam Physician; 2022 Oct; 106(4):420-426. PubMed ID: 36260899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of giant cell arteritis and polymyalgia rheumatica].
    Horvath L; Hellmich B
    Z Rheumatol; 2020 Mar; 79(2):175-185. PubMed ID: 32078029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapses in giant cell arteritis: Updated review for clinical practice.
    Alba MA; Kermani TA; Unizony S; Murgia G; Prieto-González S; Salvarani C; Matteson EL
    Autoimmun Rev; 2024 Jun; 23(6):103580. PubMed ID: 39048072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant cell arteritis: epidemiology, diagnosis, and management.
    Gonzalez-Gay MA; Martinez-Dubois C; Agudo M; Pompei O; Blanco R; Llorca J
    Curr Rheumatol Rep; 2010 Dec; 12(6):436-42. PubMed ID: 20857242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.
    Monti S; Águeda AF; Luqmani RA; Buttgereit F; Cid M; Dejaco C; Mahr A; Ponte C; Salvarani C; Schmidt W; Hellmich B
    RMD Open; 2019; 5(2):e001003. PubMed ID: 31673411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
    Matteson EL; Buttgereit F; Dejaco C; Dasgupta B
    Rheum Dis Clin North Am; 2016 Feb; 42(1):75-90, viii. PubMed ID: 26611552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of biologics in the treatment of giant cell arteritis.
    González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
    Expert Opin Biol Ther; 2019 Jan; 19(1):65-72. PubMed ID: 30513026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of giant cell arteritis.
    Pipitone N; Boiardi L; Bajocchi G; Salvarani C
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S65-70. PubMed ID: 16859599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of giant cell arteritis - current approach and new possibilities].
    Videman J; Skácelová M; Horák P; Skoumalová A; Hraboš D
    Vnitr Lek; 2022; 68(5):266-272. PubMed ID: 36283815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
    Schmidt J; Warrington KJ
    Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.